↓ Skip to main content

Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice

Overview of attention for article published in Frontiers in oncology, January 2024
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
5 X users

Readers on

mendeley
5 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice
Published in
Frontiers in oncology, January 2024
DOI 10.3389/fonc.2023.1266369
Pubmed ID
Authors

Alina Rosinha, Carlos Rabaça, Fernando Calais, João Moreira Pinto, João Vasco Barreira, Ricardo Fernandes, Rodrigo Ramos, Ana Cristina Fialho, José Palma dos Reis

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 20%
Student > Master 1 20%
Unknown 3 60%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 20%
Engineering 1 20%
Unknown 3 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2024.
All research outputs
#15,608,375
of 26,388,114 outputs
Outputs from Frontiers in oncology
#4,433
of 23,034 outputs
Outputs of similar age
#152,882
of 379,838 outputs
Outputs of similar age from Frontiers in oncology
#84
of 790 outputs
Altmetric has tracked 26,388,114 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,034 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 379,838 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 790 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.